Heart failure & cardiomyopathies

Prognostic Factors of Readmission and Mortality After First Heart Failure Hospitalization: Results from EPICAL2 Cohort

ESC Heart FailPublished Prospective cohort study

Authors' conclusion

Regardless of the prognostic state considered, we showed that comorbidities are of critical prognostic value in a real-world cohort of incident HF cases.

Study context

Population
Incident cases of first acute heart failure (HF) hospitalization alive at discharge (EPICAL2 cohort)
Participants
451 cases
Outcome
First readmission and mortality before and after readmission (prognostic factors)
Follow-up
Within the year after discharge
Methodological detailsobservational, multicentre, illness-death model
  • Observational
  • Multicentre
  • Illness-death model

Main finding

As reported in the abstract

Adjusted hazard ratio (95% CI)P value
Charlson index ≥ 8first readmission
1.6(1.1–2.3)
P = 0.011
Charlson index ≥ 8mortality before readmission
4.2(1.2–14.8)
P = 0.025
Low BPmortality before readmission
12.2(1.9–79.6)
P = 0.009
High BPmortality before readmission
6.9(1.3–36.4)
P = 0.023
Recommended dual or triple HF therapy at dischargemortality before readmission
0.2(0.1–0.7)
P = 0.014
Charlson index ≥ 8mortality after readmission
2.4(1.1–5.6)
P = 0.037
Time to first readmission (per 30 days additional)mortality after readmission
1.2(1.1–1.4)
P = 0.007

Per 30 days additional, as printed

Deaths before readmission
23 (5.1%)
First readmissions
270 (59.9%)
Readmissions followed by death of any cause
60 (22.2%)

Observational data: associations, not effects.

Original publication

Prognostic Factors of Readmission and Mortality After First Heart Failure Hospitalization: Results from EPICAL2 Cohort. ESC Heart Fail. Published 8 December 2022. doi:10.1002/ehf2.14246

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.